Client Situation
A global pharmaceutical company sought to transfer the Marketing Authorization (MA) for its leading cardiovascular medication to its newly established Brazilian subsidiary. The transfer ws part of the company’s strategy to centralize regulatory operations and enhance responsiveness to Brazil’s growing market demands. However, the process required navigating Brazil’s complex regulatory environment under ANVISA (Agencia Nacional de Vigilencia Sanitaria).
